Additionally, in AML or MDS patients, PPM1D‐mutated clones often spontaneously regressed following discontinuation of DNA‐damaging therapy and only rarely dominated as founding clones [57]. The gene discussed is PPM1D; the disease is acute myeloid leukemia.